Medical School: Albany Medical College, Albany, N.Y.
Internship: D.C. General Hospital, Washington, D.C.
Residency: McGill University Hospitals, Montreal, QC
Fellowship: Urology, McGill University Hospitals
Interests: General urology, diagnosis and treatment of benign prostatic illnesses and prostate cancer
Academic Rank: Assistant Professor of Surgery (urology), McGill University
Samuel Aronson, M.D. Urologist 1/2015
Can you imagine diagnosing and treating prostate cancer without being able to image it? That’s what we were doing. Now, for the first time in medical history, the prostate can be imaged in anatomic and functional detail with MRI.
Doctor Aronson earned his Bachelor in Science at Syracuse University and a Master’s Degree in Science Education in 1964. He went on to achieve his Medical Degree at Albany Medical College in 1968 and completed Medical Internship at D.C. General Hospital. From 1970 to 1974 he trained in General Surgery and Urology at the McGill University Hospitals. Dr. Aronson is certified as a Specialist in Urology in Quebec, the Royal College of Physicians Canada and the American Board of Urology.
Since 1976 Doctor Aronson has been in Urology Practice at the Jewish General Hospital as Assistant Professor McGill University. In 2011 Dr. Aronson specialized in the study and clinical utilization of Multi Parametric Magnetic Resonance Prostate Imaging (MRI).
Doctor Aronson is the co-author of a dozen scientific papers on Trans Rectal Prostate Ultrasound (TRUS), the most recent ones published in 2014. His innovative 2012 study of 115 men at risk of prostate cancer utilizes Prostate Cancer Risk Assessment (including PSA), Pre Programmed Follow Up, selective use of Prostate MRI and TRUS/MRI fusion targeted biopsy. The summary of this study is available at 
http://www.samuelaronsonmd.com/
Doctor Aronson is a member of the Canadian Urology Association, Quebec Urology Association, The Society of International Urology, and attends American Urology Association and European Association of Urology meetings. He studied Family Process and Interactive Teaching with Virgin Satir integrating it into his Urology Career. He was Chairman of the McGill Department of Urology Education Committee for fifteen years.
In 1991 Doctor Aronson was one of the initiators of Trans Rectal Ultrasound (TRUS) of the prostate with biopsy at the McGill University Hospitals. He continues to teach this skill to visiting Urologists and the McGill Urology Residents. He has participated in numerous conferences on Prostate Cancer, Prostate MRI and Focal Therapy including a 2 week study stay at University College Hospital London in 2013.
With Prostate Cancer Risk Assessment and MRI, Doctor Aronson differentiates men with indolent ‘not-aggressive’ prostate cancers that cause no harm from the ‘aggressive’ cancers which cause serious illness. With MRI the aggressive cancers are diagnosed earlier with greater opportunity for cure and the not-aggressive cancers safely monitored. MRI limits the over diagnosis and over treatment of not-aggressive prostate cancer, an unintended consequence of PSA Screening Biopsy.
Doctor Aronson is the author of http://www.pcamri.com/ an informative educational blog for patients and doctors. His handbook on Prostate Cancer MRI - Accurate Diagnosis and Treatment is available at http://www.pcamri.com/ and being prepared for paperback publication.
Prostate MR Imaging is complex advanced technology, time consuming to learn, interpret and clinically implement. It is becoming the basis for prostate cancer diagnosis, treatment planning and evaluation. It is key for monitoring patients at risk of prostate cancer, on active surveillance, or after treatment for residual or recurrent cancer. Prostat MRI is a major advancement in prostate cancer management, a remarkable achievement.